share_log

GRAIL Will Be Listed And Commence Regular-Way Trading On The Nasdaq Under The Symbol "GRAL" As Of June 25, 2024.

Benzinga ·  Jun 24 16:08

Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25

GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology

GRAIL, Inc. (NASDAQ:GRAL, formerly GRAIL, LLC))))), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ:ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol "GRAL" as of tomorrow, June 25, 2024.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment